Colonic motility in patients with type 1 diabetes and gastrointestinal symptoms.

Mette Winther KlingeAnne-Mette HaaseEsben Bolvig Mark Nanna SutterLotte Vinskov FynneAsbjørn Mohr DrewesVincent SchlageterSten LundPer BorghammerKlaus Krogh

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2020)

Patients with DM and GI symptoms have longer than normal GI transit times. This is only partly reversible by pyridostigmine. The increased number of retrograde colonic movements in patients could potentially explain the abnormally long transit time in proximal colon.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
ulcerative colitis
escherichia coli
patient reported outcomes
biofilm formation
skeletal muscle
cystic fibrosis
depressive symptoms
insulin resistance
candida albicans